AWIQLI: Reviews: Testimonials, Uses and Side Effects

Medication indications

Awiqli® (insulin icodec injection) is indicated for the once-weekly treatment of adults with diabetes mellitus to improve glycemic control.
Route of administration: Injectable
Molecule: insulin icodec

Patients' opinions on AWIQLI

In brief

General satisfaction level: 10.00/10 Learn more

Treatment's effectiveness: 10.00/10 Learn more

Ease of use: 10.00/10 Learn more

Adherence to prescription: 10.00/10 Learn more

Detected side effects: 5.00/10 Learn more

Improvement in the quality of life: 10.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

DannyL

on 12/7/25

In my case the conversion of 8 units of tresiba each day to awiqli was 50 units. Over a three week period blood sugars were running on the high side. Increased the dosage to 60 units for two weeks, blood sugars still a bit high. Increased dosage to 70 units for two weeks, blood sugars were more on target. Increased to 80 units for one week, found my maximum level as blood sugars were running a bit low. Reduced my dosage to 70 units which is what I have been taking as my goal dosage. Seasonal changes as well as activity level considered, 70 units seems to be my goal average. One thing to consider, once dosage is committed you are on it for a week. It was not a problem to convert to Awiqli, realistically it took about 2 months to get it dialed in. Very satisfied my endocrinologist suggested I try Awiqli.

Your message

Conditions related to this medication

Fact sheet

Diabetes (Type 2)

See the fact sheet

Fact sheet

Diabetes (Type 1)

See the fact sheet